Xing-Sheng Li Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

1/2011

Procollagen III N-terminal peptide predicts short-term prognosis and cardiac remodeling in coronary heart disease patients with metabolic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xing-Sheng Li Research Topics

Disease

2	Fibrosis (Cirrhosis) 01/2015 - 04/2011
2	Myocardial Infarction 02/2013 - 02/2008
2	Body Weight (Weight, Body) 02/2013 - 09/2005
2	Starvation 01/2007 - 09/2005
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2011
1	Inflammation (Inflammations) 05/2011
1	Alzheimer Disease (Alzheimer's Disease) 05/2011
1	Hypoxia (Hypoxemia) 03/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Coronary Disease (Coronary Heart Disease) 01/2011

Drug/Important Bio-Agent (IBA)

2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 04/2011
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2015 - 04/2011
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2013 - 02/2008
2	Peptides (Polypeptides)IBA 05/2011 - 01/2011
1	erucylphosphocholineIBA 11/2013
1	CollagenIBA 02/2013
1	Amyloid (Amyloid Fibrils)IBA 05/2011
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 04/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2011
1	ProcollagenIBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2007
1	Uncoupling Protein 1IBA 09/2005
1	Biomarkers (Surrogate Marker)IBA 09/2005
1	LeptinIBA 09/2005

Therapy/Procedure

4	Microbubbles 01/2015 - 02/2008